DNA Manufacturing Market

The DNA manufacturing market, also known as synthetic biology, involves the artificial creation of DNA molecules for research and therapeutic applications. The primary customers include pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). Key growth drivers are the rising demand for personalized medicine, the rapid expansion of cell and gene therapies, and advancements in biotechnology that enable the development of novel vaccines and biologics.

CAGR

14.62%

Compound Annual Growth Rate

Current Value

$7.32B

Estimated 2026

Projected Value

$21.8B

By 2034